S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

MediRoutes Secures Top Industry Honors at NEMTAC Transform 2026

A panel of industry experts awarded MediRoutes the Best of Show title at the NEMTAC Transform 2026 conference in Phoenix. The recognition highlights the software provider’s standout booth presence and its commitment to addressing the complex routing, scheduling, and billing pressures currently facing the non-emergency medical transportation sector.

MediRoutes Secures Top Industry Honors at NEMTAC Transform 2026
Photo: Bio & News

The annual gathering, hosted by the Non-Emergency Medical Transportation Accreditation Commission, serves as a central hub for providers, brokers, and regulators to navigate evolving industry demands. As operators contend with rising trip volumes, thinner margins, and stricter broker requirements, the MediRoutes team opted for a consultative approach rather than traditional marketing materials. By creating a dedicated conversation nook, the company prioritized direct engagement with operators over standard flyer distribution.

Peter Hicks, Executive Director at NEMTAC, noted that the company’s contribution significantly enhanced the overall experience of the exhibit hall. For their part, the MediRoutes team utilized the event to preview upcoming software developments slated for release later this autumn. Since its founding in 2008, the company has focused on providing digital infrastructure for PACE programs and transportation networks to streamline dispatching and accelerate claim processing.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!